Skip to main content
. 2018 Sep 11;13:5301–5320. doi: 10.2147/IJN.S166219

Table 1.

Physicochemical characteristics of SN-38-loaded liposomes and SN-38 entrapment inside vesicles

Sample
Physical parameters
Liposomal SN-38
Liposome composition Lipid/SN-38 (molar ratio) Particle sizea (nm) PDIb Zeta-potentialc (mV) [SN-38]d (μM) mg SN-38/mmol lipide
SLE (7.5:1) 355.3±13.2 0.472±0.011 −47.7±8.8 1,770.0±10.2 52.2±0.3
(10:1) 332.8±19.6 0.525±0.058 −54.3±10.3 1,329.0±11.3 39.2±0.3
(20:1) 196.2±9.4 0.415±0.033 −45.3±16.3 652.6±7.6 19.3±2.2
(40:1) 119.1±1.9 0.398±0.081 −36.1±8.7 331.3±8.2 9.8±0.2
DSPC/DOPS/CHOL (65:35:30) (20:1) 248.3±9.5 0.368±0.016 −32.1±17.5 713.6±6.2 19.7±1.7
EPC (20:1) 146.3±14.2 0.401±0.120 −12.6±1.5 637.5±8.9 19.1±2.6
EPC/DOPS (9:1) (20:1) 147.2±7.9 0.345±0.072 −31.4±7.4 670.2±5.7 20.3±1.6

Notes:

a

Particle size measured as Z-average mean.

b

Polydispersity index.

c

Zeta potential.

d

Bulk SN-38 concentration in the liposome suspension.

e

Drug-loading efficiency, expressed as the amount of SN-38 relative to lipid (w/w). Lipid concentration in all the samples was 10 mg/mL. Three independent batches were processed and analyzed for physicochemical characterization. The data are the mean ± SD values corresponding to three independent preparations.

Abbreviations: SN-38, irinotecan metabolite; SLE, soy bean lipid extract; DSPC, L-α-distearoyl-phosphatidylcholine; DOPS, L-α-dioleoyl-phosphatidylserine; CHOL, cholesterol; EPC, egg yolk phosphatidylcholine.